Amid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a potential treatment for chemotherapy-induced peripheral neuropathy. | Amid the rise of ...

Pfizer has found a new home for an antibody-drug conjugate it acquired in its $43 billion Seagen buyout and dropped earlier ...

Roche has decided to pay $190 million upfront for an unusual obesity mechanism after viewing preclinical data that “clearly ...

AbbVie released positive phase 3 data Thursday showing that its bispecific T-cell engager etentamig improved response rates ...

GSK is handing over $110 million upfront to Hutchmed in a deal worth up to $1.295 billion to get its hands on a ...

Ultragenyx had been flying high after its recent FDA approval for Genglycos—but the company has been brought back down to ...